Quantcast

Latest Triple-negative breast cancer Stories

Bra Size Linked To Breast Cancer Risk
2012-07-08 08:08:43

redOrbit Staff & Wire Reports - Your Universe Online The same gene that can determine a woman's breast size could also be linked to her odds of developing breast cancer, with larger cup-sizes more likely to develop tumors, according to the results of a new study California-based personal genomics and biotechnology company 23andMe. The firm reported that they were able to identify "seven single-nucleotide polymorphisms (SNPs) significantly associated with breast size, including three...

2012-07-02 23:13:22

A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise the possibility of using this type of combination therapy for different forms of breast cancer, including those that develop resistance to chemotherapy and other treatments. The study was led by researchers at the Boston University Cancer Center. Sibaji Sarkar, PhD,...

2012-06-05 23:03:19

The Canadian Breast Cancer Foundation — BC/Yukon Region (CBCF) is thrilled to announce a game-changing discovery in triple-negative breast cancer (TNBC). This breakthrough points to one of the first personalized therapies for the treatment of TNBC and reports that RSK inhibition has the potential to block TNBC recurrence. VANCOUVER, BC (PRWEB) June 05, 2012 The breakthrough research of Canadian Breast Cancer Foundation — BC/Yukon Region´s (CBCF) Doctoral Breast Cancer...

2012-06-02 23:00:06

Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the same way with African American and Caucasian patients. Chicago, IL (PRWEB) June 02, 2012 Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the same way with...

2012-05-21 19:40:58

The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research. Researchers from Tulane University Health Sciences Center have shown that panobinostat was able to destroy breast cancer cells and reduce tumor growth in mice. Approximately 15% of breast cancers are found at diagnosis to be triple negative. These aggressive tumours are missing both...

2012-05-03 15:10:40

Presentations at the 4th IMPAKT Breast Cancer Conference New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers. Focused on the biological features that make tumors more or less sensitive to important therapies, the new studies will help doctors make crucial choices about the most appropriate treatment for millions of patients. "Despite major advances in...

2012-04-05 10:19:06

American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer. There continues to be discussion about the role of low levels of vitamin D in the development of breast cancer for these women. New research published in BioMed Central's open access journal Breast Cancer Research has shown that specific genetic variations in the vitamin D receptor (VDR) and in CYP24A1 (responsible for deactivating vitamin D) are associated with an...

2012-04-04 21:16:41

An international team of scientists, including four at Simon Fraser University, has made a discovery that will change the way the most deadly form of breast cancer is treated. The journal Nature has just published the team's findings online in the paper The clonal and mutational evolution spectrum of primary triple negative breast cancers. The study is the largest genetic analysis of what were thought to be triple negative breast cancer tumors. The 59 scientists involved in this...

2012-03-27 05:17:46

(Ivanhoe Newswire) — Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin. These drugs are widely used for ovarian cancer, but as with most cancer drugs, it can be difficult to predict who will respond to therapy. A team of researchers from the Dana-Farber Cancer Institute found that this marker, telomeric allelic imbalance or tAI, could predict sensitivity to therapy in patients...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related